Diastolic heart failure: boundaries of term application

Important changes regarding the understanding of the pathogenesis of chronic heart failure (CHF) marked the beginning of the millennium, and its first decade was called the decade of diastology. Even though numerous studies convincingly proved that deterioration of the left ventricular (LV) filling pressure often precedes impairment of its systolic function and a number of factors affect (especially at the onset) mainly the diastolic function without changing the conditions of blood ejection, modern classifications and approaches to CHF treatment are primarily based on the results of LV ejection fraction (EF) assessment.

In recent years, diastolic heart failure (DHF) has been often overlooked and replaced by the ambiguous term “CHF with preserved EF”. However, sometimes authors use the term DHF extensively, since CHF based on myocardial insufficiency develops only via two mechanisms (systolic and / or diastolic dysfunction), and excluding one of the mechanisms allows to identify the underlying one. The term DHF can be used in clinical practice and cannot be replaced by the diagnosis of CHF with preserved EF. CHF with preserved EF is a broader concept which includes a full spectrum of cardiovascular diseases, complicated by the development of CHF without depression of the global LV contractility and requiring differentiated approaches to therapy. In addition, the results of repeated studies on LVEF in many patients may require reclassification of this CHF phenotype, which is established following the analysis of the baseline value of global LV contractility. We join M.R. Zile in the appeal to stop discriminating against the term “DHF” and present the boundaries of its correct application.

1. Heidenreich P.A., Bozkurt B., Aguilar D., Allen L.A., Byun J.J., Colvin M.M. et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;Apr.1:101161CIR0000000000001062. DOI: 10.1161/CIR.0000000000001062.

2. McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M. et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42(36):3599−3726. DOI: 10.1093/eurheartj/ehab368.

3. Калюжин В.В., Тепляков А.Т., Черногорюк Г.Э., Калюжина Е.В., Беспалова И.Д., Терентьева Н.Н. и др. Хроническая сердечная недостаточность: синдром или заболевание? Бюллетень сибирской медицины. 2020;19(1):134–139. DOI: 10.20538/1682-0363-2020-1-134-139.

4. Калюжин В.В., Тепляков А.Т., Беспалова И.Д., Калюжина Е.В., Останко В.Л., Терентьева Н.Н. и др. Корректная формулировка диагноза у пациента с хронической сердечной недостаточностью: реальность или несбыточная мечта? Бюллетень сибирской медицины. 2020;19(3):128−136. DOI: 10.20538/1682-0363-2020-3-128-136.

5. Warren S.E., Grossman W. Prognosis in heart failure: is systolic or diastolic dysfunction more important? Herz. 1991;16(1):324−329.

6. Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. Знакомьтесь: диастолическая сердечная недостаточность. Журнал сердечная недостаточность. 2000;1(2):40–44

7. Агеев Ф.Т. Современная концепция диастолической сердечной недостаточности. Кардиоваскулярная терапия и профилактика. 2010;9(7):97–104.

8. Tajik A.J., Jan M.F. The heart of the matter: prime time E/e’ prime! JACC Cardiovasc. Imaging. 2014;7(8):759–761. DOI: 10.1016/j.jcmg.2014.05.003.

9. Ladeiras-Lopes R., Araújo M., Sampaio F., Leite-Moreira A., Fontes-Carvalho R. The impact of diastolic dysfunction as a predictor of cardiovascular events: A systematic review and meta-analysis. Rev. Port. Cardiol. (Engl. Ed.). 2019;38(11):789−804. DOI: 10.1016/j.repc.2019.03.007.

10. Daubert M.A. Diastolic function in heart failure with reduced ejection fraction: The overlooked prognosticator? JACC Heart Fail. 2019;7(9):818−820. DOI: 10.1016/j.jchf.2019.06.005.

11. Ge H. Is diastolic dysfunction a new windsock in the risk stratification of patients with coronary heart disease? Int. J. Cardiol. 2022;346:103−104. DOI: 10.1016/j.ijcard.2021.11.037.

12. Dal Canto E., Remmelzwaal S., van Ballegooijen A.J., Handoko M.L., Heymans S., van Empel V. et al. Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction. Heart Fail. Rev. 2022;27(1):207−218. DOI: 10.1007/s10741-02009985-1.

13. Yang M., Zhang R., Tang H., Li G., Guan X., Yang Y. et al. E/E’ is a new independent predictor of recovered ejection fraction in patients with systolic heart failure undergoing ablation for atrial fibrillation. Front. Cardiovasc. Med. 2022;8:707996. DOI: 10.3389/fcvm.2021.707996.

14. Lester S.J., Tajik A.J., Nishimura R.A., Oh J.K., Khandheria B.K., Seward J.B. Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. J. Am. Coll. Cardiol. 2008;51(7):679–689. DOI: 10.1016/j.jacc.2007.09.061.

15. Беленков Ю.Н. Роль нарушений систолы и диастолы в развитии сердечной недостаточности. Терапевтический архив. 1994;6(9):3–7.

16. Калюжин В.В., Тепляков А.Т., Соловцов М.А. Роль систолической и диастолической дисфункции ЛЖ в клинической манифестации хронической сердечной недостаточности у больных, перенесших инфаркт миокарда. Терапевтический архив. 2002;74(12):15−18.

17. Калюжин В.В., Тепляков А.Т., Рязанцева Н.В., Вечерский Ю.Ю., Хлапов А.П., Колесников Р.Н. Диастола сердца. Физиология и клиническая патофизиология. Томск: Изд-во ТПУ, 2007:212.

18. Nishimura R.A., Borlaug B.A. Diastology for the clinician. J. Cardiol. 2019;73(6):445−452. DOI: 10.1016/j.jjcc.2019.03.002.

19. Obokata M., Reddy Y.N.V., Borlaug B.A. Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods. JACC Cardiovasc. Imaging. 2020;13(1Pt2):245−257. DOI: 10.1016/j.jcmg.2018.12.034.

20. Ibrahim E.H., Dennison J., Frank L., Stojanovska J. Diastolic cardiac function by MRI-Imaging capabilities and clinical applications. Tomography. 2021;7(4):893−914. DOI: 10.3390/tomography7040075.

21. Мареев В.Ю., Фомин И.В., Агеев Ф.Т., Беграмбекова Ю.Л., Васюк Ю.А., Гарганеева А.А. и др. Клинические рекомендации ОССН – РКО – РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. Кардиология. 2018;58(S6):8−161. DOI: 10.18087/cardio.2475.

22. Калюжин В.В., Тепляков А.Т., Калюжин О.В. Сердечная недостаточность. М.: Медицинское информационное агентство, 2018:376.

23. Katsi V., Georgiopoulos G., Laina A., Koutli E., Parissis J., Tsioufis C. et al. Left ventricular ejection fraction as therapeutic target: is it the ideal marker? Heart Fail. Rev. 2017;22(6):641−655. DOI: 10.1007/s10741-017-9624-5.

24. Mureddu G.F., Faggiano A. Utility and limitations of ejection fraction and of diastolic dysfunction in heart failure patients. Monaldi Arch. Chest Dis. 2019;89(1). DOI: 10.4081/monaldi.2019.1058.

25. Andrew P. Diastolic heart failure demystified. Chest. 2003;124(2):744−753. DOI: 10.1378/chest.124.2.744.

26. Zile M.R. Heart failure with preserved ejection fraction: is this diastolic heart failure? J. Am. Coll. Cardiol. 2003;41(9):1519– 1522. DOI: 10.1016/s0735-1097(03)00186-4.

27. Kessler K.M. Is diastolic heart failure synonymous with heart failure with preserved ejection fraction? J. Am. Coll. Cardiol. 2003;42(7):1335−1336. DOI: 10.1016/s07351097(03)00997-5.

28. Беленков Ю.Н., Овчинников А.Г. Должны ли мы лечить диастолическую сердечную недостаточность так же, как и систолическую? Журнал сердечная недостаточность. 2004;5(4):116–121.

29. Kass D.A. Systolic dysfunction in heart failure, in: heart failure: A companion to braunwald’s heart disease. Elsevier, 2020:36–150.e4. DOI: 10.1016/b978-0-323-60987-6.00010-7.

30. Dandel M., Hetzer R. Ventricular systolic dysfunction with and without altered myocardial contractility: Clinical value of echocardiography for diagnosis and therapeutic decision-making. Int. J. Cardiol. 2021;327:236−250. DOI: 10.1016/j.ijcard.2020.11.068.

31. Packer M., Grayburn P.A. New evidence supporting a novel conceptual framework for distinguishing proportionate and disproportionate functional mitral regurgitation. JAMA Cardiol. 2020;5(4):469−475. DOI: 10.1001/jamacardio.2019.5971.

32. Marwick T.H., Shah S.J., Thomas J.D. Myocardial strain in the assessment of patients with heart failure: a review. JAMA Cardiol. 2019;4(3):287−294. DOI: 10.1001/jamacardio.2019.0052.

33. El Torto A., Guaricci A.I., Pomarico F., Guglielmo M., Fusini L., Monitillo F. et al. Advances in multimodality cardiovascular imaging in the diagnosis of heart failure with preserved ejection fraction. Front. Cardiovasc. Med. 2022;9:758975. DOI: 10.3389/fcvm.2022.758975.

34. Chacon-Portillo M.A., Acharya T., Janardhanan R. Imaging in heart failure with preserved ejection fraction: insights into echocardiography and cardiac magnetic resonance imaging. Rev. Cardiovasc. Med. 2021;22(1):11−24. DOI: 10.31083/j.rcm.2021.01.134.

35. Barison A., Aimo A., Todiere G., Grigoratos C., Aquaro G.D., Emdin M. Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction. Heart Fail. Rev. 2022;27(1):191−205. DOI: 10.1007/s10741-020-09998-w.

36. Morariu V.I., Arnautu D.A., Morariu S.I., Popa A.M., Parvanescu T., Andor M. et al. 2D speckle tracking: a diagnostic and prognostic tool of paramount importance. Eur. Rev. Med. Pharmacol. Sci. 2022;26(11):3903−3910. DOI: 10.26355/eurrev_202206_28958.

37. Bozkurt B., Coats A.J.S., Tsutsui H., Abdelhamid C.M., Adamopoulos S., Albert N. et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur. J. Heart Fail. 2021;23(3):352−380. DOI: 10.1002/ejhf.2115.

38. Zile M.R., Baicu C.F., Gaasch W.H. Diastolic heart failure – abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med. 2004;350(19):19531959. DOI: 10.1056/NEJMoa032566.

39. Budde H., Hassoun R., Mügge A., Kovács Á., Hamdani N. Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction. Front. Physiol. 2022;13:928232. DOI: 10.3389/fphys.2022.928232.

40. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105(11):1387−1393. DOI: 10.1161/hc1102.105289.

41. Sousa C. Assessment of diastolic function: How much more evidence do we need? Rev. Port. Cardiol. (Engl. Ed.). 2019;38(11):805−807. DOI: 10.1016/j.repc.2020.01.003.

42. Rabkin S.W. Heart failure with reduced ejection fraction and diastolic dysfunction (HrEFwDD): Time for a new clinical entity. Int. J. Cardiol. 2022;363:123−124. DOI: 10.1016/j.ijcard.2022.06.056.

43. Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F. 3rd, Dokainish H., Edvardsen T. et al. Houston, Texas; Oslo, Norway; Phoenix, Arizona; Nashville, Tennessee; Hamilton, Ontario, Canada; Uppsala, Sweden; Ghent and Liège, Belgium; Cleveland, Ohio; Novara, Italy; Rochester, Minnesota; Bucharest, Romania; and St. Louis, Missouri. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging. 2016;17(12):1321−1360. DOI: 10.1093/ehjci/jew082.

44. Pieske B., Tschöpe C., de Boer R.A., Fraser A.G., Anker S.D., Donal E. et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur. J. Heart Fail. 2020;22(3):391−412. DOI: 10.1002/ejhf.1741.

45. Ashkir Z., Myerson S., Neubauer S., Carlhäll C.J., Ebbers T., Raman B. Four-dimensional flow cardiac magnetic resonance assessment of left ventricular diastolic function. Front. Cardiovasc. Med. 2022;9:866131. DOI: 10.3389/fcvm.2022. 866131.

46. Hagendorff A., Stöbe S., Kandels J., de Boer R., Tschöpe C. Diagnostic role of echocardiography for patients with heart failure symptoms and preserved left ventricular ejection fraction. Herz. 2022;47(4):293−300. DOI: 10.1007/s00059-022-05118-6.

47. Young K.A., Scott C.G., Rodeheffer R.J., Chen H.H. Incidence of preclinical heart failure in a community population. J. Am. Heart. Assoc. 2022;11(15):e025519. DOI: 10.1161/JAHA.122.025519.

48. Wenzel J.P., Kellen R.B., Magnussen C., Blankenberg S., Schrage B., Schnabel R. et al. Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction. Clin. Res. Cardiol. 2022;111(4):416−427. DOI: 10.1007/s00392-021-01907-x.

49. Vasan R.S., Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation. 2000;101(17):2118−2121. DOI: 10.1161/01.cir.101.17.2118.

50. Frigerio M., Aguggini G. Diastolic heart failure. Ital. Heart J. 2004;5(S.6):48S−54S.

51. Останко В.Л., Калачева Т.П., Калюжина Е.В., Лившиц И.К., Шаловай А.А., Черногорюк Г.Э. и др. Биологические маркеры в стратификации риска развития и прогрессирования сердечно-сосудистой патологии: настоящее и будущее. Бюллетень сибирской медицины. 2018;17(4):264−280. DOI: 10.20538/1682-0363-2018-4-264-280.

52. Bayes-Genis A., Cediel G., Domingo M., Codina P., Santiago E., Lupón J. Biomarkers in heart failure with preserved ejection fraction. Card. Fail. Rev. 2022;8:e20. DOI: 10.15420/cfr.2021.37.

53. Morfino P., Aimo A., Castiglione V., Vergaro G., Emdin M., Clerico A. Biomarkers of HFpEF: natriuretic peptides, high-sensitivity troponins and beyond. J. Cardiovasc. Dev. Dis. 2022;9(8):256. DOI: 10.3390/jcdd9080256.

54. Litwin S.E., Zile M.R. Should we test for diastolic dysfunction? How and how often? JACC Cardiovasc. Imaging. 2020;13(1Pt2):297−309. DOI: 10.1016/j.jcmg. 2019.02.029.

55. MacNamara J.P., Sarma S. Faltering under pressure: limitations to noninvasive diastolic function assessments. J. Am. Heart Assoc. 2021;10(18):e023189. DOI: 10.1161/JAHA.121.023189.

56. Овчинников А.Г., Агеев Ф.Т., Алёхин М.Н., Беленков Ю.Н., Васюк Ю.А., Галявич А.С. и др. Диастолическая трансторакальная стресс-эхокардиография с дозированной физической нагрузкой в диагностике сердечной недостаточности с сохраненной фракцией выброса: показания, методология, интерпретация результатов. Согласованное мнение экспертов, выработанное под эгидой ФГБУ «Национальный медицинский исследовательский центр кардиологии» МЗ РФ, Общества специалистов по сердечной недостаточности (ОССН) и Российской ассоциации специалистов ультразвуковой диагностики в медицине (РАСУДМ). Кардиология. 2020;60(12):48−63. DOI: 10.18087/cardio.2020.12.n1219.